Medtech Insight takes device and diagnostics stakeholders inside the trends shaping global medical technology. Featuring Digital Health Roundup and other series, expert journalists unpack digital health, device approvals, policy shifts and market dynamics. Stay ahead at https://insights.citeline.com/medtech-insight with newsletters and daily updates on the evolving device and diagnostics landscape. For any podcast feedback or queries, you can now reach us at podcasts@norstella.com.
Digital Health Roundup: BD’s $19Bn Tariff Deal, Longevity, GLP-1 Tools Chasing Proof
In this month's podcast, Shubham Singh discusses BD’s $19bn US investment deal for tariff relief; Brian Bossetta, NET Recovery’s stimulant-use device; George Underwood, Reset Health’s GLP-1 adherence data; and Marion Webb, Hillary Lin’s evidence-based longevity care;
16 Sept 2026
Digital Health Roundup: Oura Plans IPO, FDA’s Home Health, Digital Tools For Alzheimer’s Detection
In this month: Marion Webb highlights Oura’s IPO, new partnerships, and a class-action lawsuit. George Underwood discusses digital tools for early Alzheimer’s detection and Brian Bossetta FDA’s READI-Home Innovation Challenge. Shubham Singh interviews AI longevity firm BAiO.
19 Aug 2026
Medtech Insight Trailer
6 Aug 2026
Digital Health Roundup: CE Mark For Vision-Restoring Implant, AI Chatbot Rules, MS Deal
Science Corp.'s PRIMA brain-computer interface receives CE mark for restoring central vision in AMD patients. Viz.ai partners with Cortechs.ai on MS tracking. AMA urges Congress to regulate mental health AI chatbots. MedLink earns Mayo Clinic Platform qualification.
22 Jun 2026
The Insight Room: Catching the Deadliest Cancer Earlier - Inside the PRECEDE–Azenta Partnership
Pancreatic cancer has the lowest survival rate of any major cancer — just 13%, largely because it's so hard to catch early. Changing that takes more than a lab breakthrough. It takes the unglamorous infrastructure to collect, track, and safeguard patient samples across dozens of institutions, reliably enough that researchers can trust what they find.
In this episode, host Krishna talks with Margaret Caspler, President and CEO of the PRECEDE Foundation — a consortium of more than 65 academic medical centers working to raise pancreatic cancer survival from 13% to 50% — and Kathi Shea, Chief Client Solutions Officer for Repository at Azenta Life Sciences, who has spent three decades in biorepository science. Together they explore why early detection has lagged, what it takes to run a biospecimen network at scale, and how a public-private partnership can do what neither side could alone.
Follow Medtech Insight to stay ahead of every shift in the device and diagnostics landscape.
1 Jun 2026
Ambu CEO Britt Meelby Jensen on EU competitivity and compromise
22 May 2026
MHRA’s Rob Reid updates on timings for CE marking, pre-market SI and possible EU MDR outcomes
MHRA’s Rob Reid spoke to Ashley Yeo at MTF 2026 on issues affecting UK and Great Britain medtech regulation
15 May 2026
ABHI's Steve Lee on the UK MHRA's frictionless regulatory future for the UK
The MHRA’s spring 2026 CE-marking consultation, the progress of UK medtech statutory instruments and the European Commission’s proposed revision of the MDR and IVDR were top of mind for the Association of British HealthTech Industries' Steve Lee as he did the rounds – and the panels – at the MedTech Forum 2026.
Contact Medtech Insight Podcasts
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Medtech Insight Podcasts?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
